-
RBC Capital Reiterates Outperform Rating on Inovio Pharmaceuticals (INO)
-
Inovio Pharmaceuticals (INO) $9M Grant Formalizes Entry Into Coronavirus Virus Solution Mix - RBC
-
Inovio Pharmaceuticals (INO) PT Lowered to $11 at RBC Capital
-
Inovio Pharmaceuticals (INO) PT Lowered to $12 at RBC Capital
-
Inovio Pharmaceuticals (INO) PT Lowered to $13 at RBC Capital
-
Inovio Pharmaceuticals (INO) PT Raised to $14 at RBC Capital
-
Inovio Pharmaceuticals to Participate in Upcoming Investment Conferences
-
RBC Capital Starts Inovio Pharmaceuticals (INO) at Outperform
-
Inovio Pharma (INO) Prices 12.5M Shares at $6
-
Inovio Announces Pricing of Public Offering of Common Stock
-
Inovio Pharma (INO) to Offer $75M in Common Stock
-
Inovio Announces Proposed Public Offering of Common Stock
-
Inovio Pharmaceuticals to Participate in Upcoming Investment Conferences
-
Notable Mergers and Acquisitions 3/14: (APO)/(TFM) (HOT) (NQ) (INO)
-
Streetinsider.com's Hot Lunchtime Reads 2/17: (TWTR) (INO) (PLUG) (PCLN)
-
Pre-Open Stock Movers 9/9: (MOLX) (UNIS) (ISIS) Higher; (BIOD) (HSOL) (SCTY) Lower (more...)
-
Notable Analyst Rating Changes 08/16: (P) (JBLU) (APC) Upgraded; (GIS) (INO) (AA) Downgraded